Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia

Phase 2 Completed 180 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to determine the efficacy (how well the drug works), safety, and side effects of the study medication compared to placebo in the treatment of the negative symptoms of schizophrenia in adults.

Timeline

Start: 2003-05
Primary completion: —
Completion: 2003-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	R209130	Unknown	—	—

Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia

Summary

Timeline

Drugs

Indications